drugset / Trial / NCT00175227

Prevention of Contrast-Induced Nephropathy

NCT00175227 ↗

RandomizedParallel-groupQuadruple-blindPrevention

Summary

Patients with pre-existing kidney disease are at high risk of acute renal failure when exposed to radio-contrast dyes, for example during a cardiac angiogram. The investigators hypothesize that an infusion of saline + furosemide + mannitol will reduce rates of contrast-induced nephropathy when compared with saline infusion controls.

Timeline

Start
1996-05
Primary completion
2000-10
Completion
—

Outcome

Missed primary endpoint

paper Contrast-induced nephropathy occurred in 23 (50%) intervention patients versus 13 (28%) controls (relative risk, 1.77; 95% confidence interval, 1.03 to 3.05; P = 0.03; PMID 19535188 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Furosemide Other / unclassified 100 mg —
Subject Mannitol Diagnostic / imaging agent 25 g —